95 related articles for article (PubMed ID: 21957774)
1. [FARIM - FARmakoterapie po Infarktu Myokardu (Post-Myocardial Infarction Pharmacotherapy Study)].
Spinar J; Vítovec J; Spinarová L;
Vnitr Lek; 2011 Sep; 57(9):778-84. PubMed ID: 21957774
[TBL] [Abstract][Full Text] [Related]
2. [BRNO Register 2: post-myocardial infarction pharmacotherapy].
Spinar J; Ludka O; Sepsi M; Schildberger J; Dusek L; Jarkovský J;
Vnitr Lek; 2010 Jun; 56(6):533-40. PubMed ID: 20681466
[TBL] [Abstract][Full Text] [Related]
3. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
Hudson M; Richard H; Pilote L
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
[TBL] [Abstract][Full Text] [Related]
4. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
6. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
[TBL] [Abstract][Full Text] [Related]
7. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
Gislason GH; Rasmussen JN; Abildstrøm SZ; Gadsbøll N; Buch P; Friberg J; Rasmussen S; Køber L; Stender S; Madsen M; Torp-Pedersen C
Eur Heart J; 2006 May; 27(10):1153-8. PubMed ID: 16399775
[TBL] [Abstract][Full Text] [Related]
8. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
9. Discontinuation of statin therapy following an acute myocardial infarction: a population-based study.
Daskalopoulou SS; Delaney JA; Filion KB; Brophy JM; Mayo NE; Suissa S
Eur Heart J; 2008 Sep; 29(17):2083-91. PubMed ID: 18664465
[TBL] [Abstract][Full Text] [Related]
10. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
[TBL] [Abstract][Full Text] [Related]
11. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
[TBL] [Abstract][Full Text] [Related]
12. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
13. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
[TBL] [Abstract][Full Text] [Related]
14. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
[TBL] [Abstract][Full Text] [Related]
15. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
16. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
17. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.
Cambou JP; Simon T; Mulak G; Bataille V; Danchin N
Arch Mal Coeur Vaiss; 2007; 100(6-7):524-34. PubMed ID: 17893635
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacotherapy following myocardial infarction].
Spinarová L; Spinar J; Vítovec J
Vnitr Lek; 2011 Nov; 57(11):966-9. PubMed ID: 22165705
[TBL] [Abstract][Full Text] [Related]
19. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
Corp EV; Antoniou S; Wright PG; Khachi H; Vercaeren S; Wald DS
QJM; 2009 Dec; 102(12):843-9. PubMed ID: 19828644
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
Tuppin P; Neumann A; Danchin N; de Peretti C; Weill A; Ricordeau P; Allemand H
Arch Cardiovasc Dis; 2010; 103(6-7):363-75. PubMed ID: 20800800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]